18.07.2013 - Obesity drug maker Vivus, embroiled in a bitter proxy war with its top shareholder First Manhattan, said on Wednesday that FMC had rejected an offer to give the sides equal...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)